Chronic Low Back Pain Patients' Expectations Toward Physiotherapy
Launched by HAUTE ECOLE DE SANTÉ VAUD · Apr 23, 2014
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
INTRODUCTION
Chronic low back pain (CLBP) is defined as "pain and discomfort, localised below the costal margin and above the inferior gluteal folds, with or without referred leg pain" persisting for at least 12 weeks. It is classified as non-specific when "not attributable to a recognisable, known specific pathology, disorder, radicular syndrome or cauda equina syndrome". It is a very frequent condition, one year prevalence being around 25% for men and 35% for women. It can greatly alter functional capacity and quality of life. Including care, sick leave and work loss, it accounts for mos...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • working age group (18 to 65 years old)
- • have a medically confirmed non-specific chronic low-back pain
- Exclusion Criteria:
- • severe mental illness
- • concurrent illness or co-morbidity interfering with the course of treatment.
About Haute Ecole De Santé Vaud
Haute École de Santé Vaud (HESAV) is a prestigious institution dedicated to advancing education and research in health sciences. Located in Switzerland, HESAV focuses on fostering innovation and excellence in clinical practices through interdisciplinary collaboration and evidence-based methodologies. The institution actively sponsors clinical trials aimed at enhancing healthcare outcomes, improving patient safety, and contributing to the body of medical knowledge. With a commitment to quality and ethical standards, HESAV plays a pivotal role in shaping the future of health care through rigorous research and training of health professionals.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lausanne, Vaud, Switzerland
Patients applied
Trial Officials
Claude Pichonnaz, PT, MSc
Study Director
Hautre Ecole de Santé Vaud, physiotherapy department
Rose-Anna Foley, PhD
Principal Investigator
Haute Ecole de Santé Vaud, research unit
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials